CMB TECH NV (CMBT.BR) Fundamental Analysis & Valuation

EBR:CMBT • BE0003816338

Current stock price

10.76 EUR
+0.1 (+0.94%)
Last:

This CMBT.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CMBT.BR Profitability Analysis

1.1 Basic Checks

  • In the past year CMBT has reported negative net income.
  • CMBT had a positive operating cash flow in the past year.
  • CMBT had positive earnings in 4 of the past 5 years.
  • In multiple years CMBT reported negative operating cash flow during the last 5 years.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.67%, CMBT is in line with its industry, outperforming 44.87% of the companies in the same industry.
  • CMBT's Return On Equity of 12.04% is fine compared to the rest of the industry. CMBT outperforms 61.54% of its industry peers.
  • The Return On Invested Capital of CMBT (4.04%) is worse than 67.95% of its industry peers.
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROIC 4.04%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • CMBT has a better Profit Margin (17.42%) than 79.49% of its industry peers.
  • CMBT's Profit Margin has declined in the last couple of years.
  • CMBT has a better Operating Margin (23.08%) than 61.54% of its industry peers.
  • In the last couple of years the Operating Margin of CMBT has declined.
  • Looking at the Gross Margin, with a value of 52.84%, CMBT is in line with its industry, outperforming 58.97% of the companies in the same industry.
  • CMBT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

0

2. CMBT.BR Health Analysis

2.1 Basic Checks

  • CMBT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for CMBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.84, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
  • CMBT has a worse Altman-Z score (0.84) than 82.05% of its industry peers.
  • A Debt/Equity ratio of 1.96 is on the high side and indicates that CMBT has dependencies on debt financing.
  • CMBT's Debt to Equity ratio of 1.96 is on the low side compared to the rest of the industry. CMBT is outperformed by 91.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.59
WACC6.8%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • A Current Ratio of 0.62 indicates that CMBT may have some problems paying its short term obligations.
  • The Current ratio of CMBT (0.62) is worse than 93.59% of its industry peers.
  • CMBT has a Quick Ratio of 0.62. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.51, CMBT is not doing good in the industry: 89.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.51
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. CMBT.BR Growth Analysis

3.1 Past

  • The earnings per share for CMBT have decreased strongly by -106.08% in the last year.
  • The earnings per share for CMBT have been decreasing by -20.73% on average. This is quite bad
  • CMBT shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.96%.
  • CMBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.60% yearly.
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%

3.2 Future

  • CMBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 90.76% yearly.
  • Based on estimates for the next years, CMBT will show a quite strong growth in Revenue. The Revenue will grow by 10.67% on average per year.
EPS Next Y650.86%
EPS Next 2Y144.22%
EPS Next 3Y90.76%
EPS Next 5YN/A
Revenue Next Year30.41%
Revenue Next 2Y19.87%
Revenue Next 3Y10.67%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

4

4. CMBT.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CMBT. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 10.07, the valuation of CMBT can be described as reasonable.
  • CMBT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CMBT is cheaper than 85.90% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CMBT to the average of the S&P500 Index (22.70), we can say CMBT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.07
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • CMBT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CMBT is more expensive than 71.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.16
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • CMBT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CMBT's earnings are expected to grow with 90.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y144.22%
EPS Next 3Y90.76%

0

5. CMBT.BR Dividend Analysis

5.1 Amount

  • No dividends for CMBT!.
Industry RankSector Rank
Dividend Yield 0%

CMBT.BR Fundamentals: All Metrics, Ratios and Statistics

CMB TECH NV

EBR:CMBT (3/24/2026, 12:02:04 PM)

10.76

+0.1 (+0.94%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-26
Earnings (Next)05-19
Inst Owners12.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.40B
Revenue(TTM)2.36B
Net Income(TTM)306.64M
Analysts83.33
Price Target12.06 (12.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend4.92
Dividend Growth(5Y)116.35%
DP7.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.2%
Min EPS beat(2)-198.04%
Max EPS beat(2)-148.37%
EPS beat(4)0
Avg EPS beat(4)-136.26%
Min EPS beat(4)-198.04%
Max EPS beat(4)-49.61%
EPS beat(8)3
Avg EPS beat(8)39.77%
EPS beat(12)7
Avg EPS beat(12)35.97%
EPS beat(16)10
Avg EPS beat(16)32.67%
Revenue beat(2)2
Avg Revenue beat(2)34.8%
Min Revenue beat(2)22.8%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)17.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)22.7%
Revenue beat(12)10
Avg Revenue beat(12)33.52%
Revenue beat(16)14
Avg Revenue beat(16)39.69%
PT rev (1m)7.06%
PT rev (3m)12.72%
EPS NQ rev (1m)-10.2%
EPS NQ rev (3m)7.48%
EPS NY rev (1m)-5.59%
EPS NY rev (3m)-7.04%
Revenue NQ rev (1m)-2.1%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)-1.26%
Revenue NY rev (3m)-1.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.07
P/S 2.24
P/FCF N/A
P/OCF 12.1
P/B 1.55
P/tB 1.67
EV/EBITDA 13.16
EPS(TTM)-0.19
EYN/A
EPS(NY)1.07
Fwd EY9.93%
FCF(TTM)-2.54
FCFYN/A
OCF(TTM)0.89
OCFY8.27%
SpS4.8
BVpS6.95
TBVpS6.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROCE 5.39%
ROIC 4.04%
ROICexc 4.04%
ROICexgc 4.14%
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA 6.9
Cap/Depr 395.78%
Cap/Sales 71.33%
Interest Coverage 1.53
Cash Conversion 45.05%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.51
Altman-Z 0.84
F-Score3
WACC6.8%
ROIC/WACC0.59
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
EPS Next Y650.86%
EPS Next 2Y144.22%
EPS Next 3Y90.76%
EPS Next 5YN/A
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%
Revenue Next Year30.41%
Revenue Next 2Y19.87%
Revenue Next 3Y10.67%
Revenue Next 5YN/A
EBIT growth 1Y-35.16%
EBIT growth 3Y22.92%
EBIT growth 5Y-6.34%
EBIT Next Year146.31%
EBIT Next 3Y31.85%
EBIT Next 5YN/A
FCF growth 1Y-499.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.43%
OCF growth 3YN/A
OCF growth 5YN/A

CMB TECH NV / CMBT.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CMB TECH NV (CMBT.BR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CMBT.BR.


Can you provide the valuation status for CMB TECH NV?

ChartMill assigns a valuation rating of 4 / 10 to CMB TECH NV (CMBT.BR). This can be considered as Fairly Valued.


How profitable is CMB TECH NV (CMBT.BR) stock?

CMB TECH NV (CMBT.BR) has a profitability rating of 3 / 10.


What is the financial health of CMB TECH NV (CMBT.BR) stock?

The financial health rating of CMB TECH NV (CMBT.BR) is 0 / 10.


How sustainable is the dividend of CMB TECH NV (CMBT.BR) stock?

The dividend rating of CMB TECH NV (CMBT.BR) is 0 / 10 and the dividend payout ratio is 7.67%.